258 related articles for article (PubMed ID: 18757481)
21. Antigen-evoked mast cell degranulation in the isolated rat heart: no effect on subsequent ischemia-reperfusion induced damage.
Engels W; Van Haaster CM; Vleeming W; Van der Vusse GJ
Inflamm Res; 1997 Feb; 46(2):40-5. PubMed ID: 9085142
[TBL] [Abstract][Full Text] [Related]
22. Gs-coupled adenosine receptors differentially limit antigen-induced mast cell activation.
Hua X; Chason KD; Jania C; Acosta T; Ledent C; Tilley SL
J Pharmacol Exp Ther; 2013 Feb; 344(2):426-35. PubMed ID: 23149337
[TBL] [Abstract][Full Text] [Related]
23. Potential role of A2A adenosine receptor in traumatic optic neuropathy.
Ahmad S; Fatteh N; El-Sherbiny NM; Naime M; Ibrahim AS; El-Sherbini AM; El-Shafey SA; Khan S; Fulzele S; Gonzales J; Liou GI
J Neuroimmunol; 2013 Nov; 264(1-2):54-64. PubMed ID: 24090652
[TBL] [Abstract][Full Text] [Related]
24. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes.
Yang Z; Day YJ; Toufektsian MC; Xu Y; Ramos SI; Marshall MA; French BA; Linden J
Circulation; 2006 Nov; 114(19):2056-64. PubMed ID: 17060376
[TBL] [Abstract][Full Text] [Related]
25. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection.
Parikh V; Singh M
Pharmacol Res; 1999 Aug; 40(2):129-37. PubMed ID: 10433871
[TBL] [Abstract][Full Text] [Related]
26. A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells.
Ge ZD; van der Hoeven D; Maas JE; Wan TC; Auchampach JA
J Mol Cell Cardiol; 2010 Aug; 49(2):280-6. PubMed ID: 20132822
[TBL] [Abstract][Full Text] [Related]
27. Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts.
Zhou Z; Rajamani U; Labazi H; Tilley SL; Ledent C; Teng B; Mustafa SJ
Purinergic Signal; 2015 Jun; 11(2):263-73. PubMed ID: 25911169
[TBL] [Abstract][Full Text] [Related]
28. Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning.
Morrison RR; Tan XL; Ledent C; Mustafa SJ; Hofmann PA
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2523-9. PubMed ID: 17675570
[TBL] [Abstract][Full Text] [Related]
29. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
[TBL] [Abstract][Full Text] [Related]
30. Post-ischemic cardioprotection by A2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway.
Boucher M; Pesant S; Falcao S; de Montigny C; Schampaert E; Cardinal R; Rousseau G
J Cardiovasc Pharmacol; 2004 Mar; 43(3):416-22. PubMed ID: 15076226
[TBL] [Abstract][Full Text] [Related]
31. Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart.
Lozza G; Conti A; Ongini E; Monopoli A
Pharmacol Res; 1997 Jan; 35(1):57-64. PubMed ID: 9149317
[TBL] [Abstract][Full Text] [Related]
32. Role of endothelium in ischaemia-induced myocardial dysfunction of isolated working hearts: cardioprotection by activation of adenosine A(2A) receptors.
Maddock HL; Broadley KJ; Bril A; Khandoudi N
J Auton Pharmacol; 2001; 21(5-6):263-71. PubMed ID: 12123472
[TBL] [Abstract][Full Text] [Related]
33. Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue.
Yang XM; Gadde S; Audia JP; Alvarez DF; Downey JM; Cohen MV
J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):371-376. PubMed ID: 30744423
[TBL] [Abstract][Full Text] [Related]
34. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
Glover DK; Riou LM; Ruiz M; Sullivan GW; Linden J; Rieger JM; Macdonald TL; Watson DD; Beller GA
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1851-8. PubMed ID: 15591104
[TBL] [Abstract][Full Text] [Related]
35. Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist.
Patel RA; Glover DK; Broisat A; Kabul HK; Ruiz M; Goodman NC; Kramer CM; Meerdink DJ; Linden J; Beller GA
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H637-42. PubMed ID: 19502555
[TBL] [Abstract][Full Text] [Related]
36. Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.
Duffy SM; Cruse G; Brightling CE; Bradding P
Eur J Immunol; 2007 Jun; 37(6):1653-62. PubMed ID: 17474152
[TBL] [Abstract][Full Text] [Related]
37. Effects of A(3) adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart.
Harrison GJ; Cerniway RJ; Peart J; Berr SS; Ashton K; Regan S; Paul Matherne G; Headrick JP
Cardiovasc Res; 2002 Jan; 53(1):147-55. PubMed ID: 11744023
[TBL] [Abstract][Full Text] [Related]
38. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells.
Day YJ; Huang L; McDuffie MJ; Rosin DL; Ye H; Chen JF; Schwarzschild MA; Fink JS; Linden J; Okusa MD
J Clin Invest; 2003 Sep; 112(6):883-91. PubMed ID: 12975473
[TBL] [Abstract][Full Text] [Related]
39. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade.
Philipp S; Yang XM; Cui L; Davis AM; Downey JM; Cohen MV
Cardiovasc Res; 2006 May; 70(2):308-14. PubMed ID: 16545350
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
